NDC 49281-574 – Beyfortus
Nirsevimab 100 mg/mL · Injection · Intramuscular
Product NDC49281-574
Product details
- Brand name
- Beyfortus
- Generic name
- Nirsevimab
- Labeler
- Sanofi Vaccines US Inc.
- Dosage form
- Injection
- Route
- Intramuscular
- Marketing category
- BLA · BLA761328
- Marketed since
- July 18, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody
Active ingredients
- Nirsevimab 100 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 49281-574-15 | 5 SYRINGE in 1 CARTON (49281-574-15) / 1 mL in 1 SYRINGE | Jul 18, 2023 |
| 49281-574-88 | 1 SYRINGE in 1 CARTON (49281-574-88) / 1 mL in 1 SYRINGE | Jul 18, 2023 |
Other Beyfortus products
- 49281-575 Nirsevimab 100 mg/mL · Injection · Sanofi Vaccines US Inc.